This HTML5 document contains 222 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n8https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36030528
rdf:type
wikibase:Item
schema:description
artigo científico (publicado na 2015) επιστημονικό άρθρο 2015年論文 vetenskaplig artikel 2015년 논문 scienca artikolo գիտական հոդված научни чланак teaduslik artikkel tieteellinen artikkeli 2015年论文 2015年論文 2015年の論文 bài báo khoa học artigo científico article scientifique (publié 2015) سائنسی مضمون სამეცნიერო სტატია научная статья artículu científicu espublizáu en 2015 мақолаи илмӣ artikull shkencor 2015年论文 wissenschaftlicher Artikel vědecký článek artigo científico (publicado na 2015) 2015年论文 2015年论文 article científic artículo científico publicado en 2015 naučni članak мақолаи илмӣ vitskapeleg artikkel наукова стаття, опублікована у вересні 2015 article scientific mokslinis straipsnis 2015年論文 2015年论文 научни чланак articolo scientifico vedecký článok bilimsel makale videnskabelig artikel (udgivet 2015) vitenskapelig artikkel مقالة علمية نشرت بتاريخ 4-9-2015 научна статия artykuł naukowy 2015年论文 tudományos cikk 2015年論文 scientific article 2015年論文 artikulong pang-agham מאמר מדעי articol științific 2015 nî lūn-bûn ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ บทความทางวิทยาศาสตร์ wetenschappelijk artikel مقالهٔ علمی
p:P577
wds:Q36030528-968AC0CE-7B1F-49F1-809D-D751B7DDFC3D
wdt:P577
2015-09-04T00:00:00Z
p:P407
wds:Q36030528-01DC23ED-6458-42F7-AA0A-FC8A3F617AAA
wdt:P407
wd:Q1860
p:P2888
wds:Q36030528-F5873176-283E-47C2-9DF1-3813DB209C54
wdt:P2888
n8:s13063-015-0898-4
p:P2860
wds:Q36030528-A6D47689-D0CD-4EB7-AD1A-7C2E14E060EB wds:Q36030528-AAF9F4D0-8775-4D67-9FC5-08C92BAB3154 wds:Q36030528-B0C06BA9-DA6F-4544-BBD6-6A96D834C923 wds:Q36030528-B527E669-4904-4A3F-81A1-B593486B4C40 wds:Q36030528-FAA50B00-8496-4617-B211-F9F0AF1E92B8 wds:Q36030528-DD31151C-28D6-4F7E-9C9F-2DA42868905D wds:Q36030528-E5A369F8-E1F2-4050-8B24-9ED997DBA251 wds:Q36030528-ECD44FB5-FE15-4725-AF84-7A423D0393D0 wds:Q36030528-ED0C61A4-EB8B-41A5-97C1-4CCB63A7B90F wds:Q36030528-F3899B28-7A75-4ECE-BD91-02C7D03B106E wds:Q36030528-F9CAB353-27FD-4DF2-862F-2665A832331F wds:Q36030528-1B2D5C35-F4E0-40E6-8A18-8BD86DE38E4B wds:Q36030528-26E868BB-EFB6-4411-B345-4550105360EF wds:Q36030528-2B97CD54-A0A3-42CF-A8F6-281BDB89441A wds:Q36030528-2DE0D237-5ABD-40FC-A6D6-DCB3FC0CD17B wds:Q36030528-2DF7139F-419E-4AB3-AB36-2FCF2617B7B9 wds:Q36030528-02908F17-EEA9-44B5-803F-5DCF96E71DE3 wds:Q36030528-0DCD4C84-4E74-42D2-A44D-3E21D725389A wds:Q36030528-0F81A819-7A5F-4B11-B26F-255B4B9EF0A6 wds:Q36030528-0FD807CC-927E-437B-8147-7106C81910B8 wds:Q36030528-1255D4A3-103D-4D74-9F17-26B6DFF52C3D wds:Q36030528-12B7C142-6144-49E3-B33B-659C803178D2 wds:Q36030528-4769DA36-A962-45E7-8821-E1BFFD9695C5 wds:Q36030528-4A218437-5C36-4559-9BA6-8345C28D0415 wds:Q36030528-4E63A84B-41A3-4FAC-BC26-8DB0A6A3D973 wds:Q36030528-555239AF-6C7E-415B-9251-DD7DB39CD4D3 wds:Q36030528-5EACC23B-2FD3-474A-96F6-E1DF5E267771 wds:Q36030528-610DE9DC-2773-42F9-B330-678DDA6FE103 wds:Q36030528-616F9C41-A452-4A41-8D4C-F4184A5D1D84 wds:Q36030528-3224610F-49FD-411B-B701-49FC92E628A6 wds:Q36030528-3A696768-67E5-4821-935B-F80C2407EA07 wds:Q36030528-3CAEDD0A-9E26-48B1-ADDF-85AED5B93B97 wds:Q36030528-437E6FD8-82BA-45E3-847C-632678293D35 wds:Q36030528-89AD98E7-AB5B-43BF-9F58-6F28CBDC7709 wds:Q36030528-8BC18BBA-E457-4BB7-8861-1A770E97FFF0 wds:Q36030528-8F5061C2-05D3-4FD5-818B-91F9613FB335 wds:Q36030528-90FAA677-F061-405B-AED8-80AFA09AB41D wds:Q36030528-9E98F068-6E40-4686-8126-93BA0B134F79 wds:Q36030528-9FD5D0D9-033D-40C3-8633-6448D6D39AAB wds:Q36030528-679B61E3-C115-4CB7-AC3A-8DDCBBFBC312 wds:Q36030528-868FB74E-FEAE-4F98-B6B6-C872CEECB12A wds:Q36030528-8824B2E9-AA73-463A-A964-E7C2DFF0DBC8 wds:Q36030528-B8F72D60-6D36-414F-B2F2-705548D0EFE2 wds:Q36030528-BF494C10-504A-4E29-B689-550FDAA75174 wds:Q36030528-C298B621-4880-498A-8FCD-20330C3D3F92 wds:Q36030528-CA138F33-EB29-437D-BE5D-3A34B3725D75 wds:Q36030528-CB20672E-8407-4381-B1CD-A74B14747FA7 wds:Q36030528-CF5F88A7-A128-4549-847C-69209AEFF48E wds:Q36030528-D23C3439-5B58-4541-A5E3-6B8376A5685A
wdt:P2860
wd:Q46116845 wd:Q36060497 wd:Q43848353 wd:Q37718863 wd:Q42850914 wd:Q29617563 wd:Q82339270 wd:Q46621989 wd:Q82339257 wd:Q37733753 wd:Q24245569 wd:Q61649811 wd:Q81670366 wd:Q35711431 wd:Q52058919 wd:Q46522932 wd:Q49142080 wd:Q36925564 wd:Q53111119 wd:Q47837690 wd:Q34098622 wd:Q34163710 wd:Q35003773 wd:Q69660651 wd:Q50602710 wd:Q34176187 wd:Q29620669 wd:Q28256895 wd:Q34105149 wd:Q82362100 wd:Q54523711 wd:Q56627595 wd:Q67527205 wd:Q83081045 wd:Q42923039 wd:Q36933765 wd:Q29614696 wd:Q48792975 wd:Q43424706 wd:Q48691914 wd:Q42844276 wd:Q56620375 wd:Q45139213 wd:Q35752573 wd:Q43138658 wd:Q51081226 wd:Q72030226 wd:Q37826153 wd:Q38156106
p:P2093
wds:Q36030528-780DB87F-75FB-4CF5-B3E3-342AA9B64C65 wds:Q36030528-34B7D336-BCA5-498E-8F50-B7E25BFC41DA wds:Q36030528-29DCF682-6D20-476C-A686-57E74918D850 wds:Q36030528-A3D3C3D7-3333-4211-9CDB-6732BF5996D5
wdt:P2093
Koen M van Nieuwenhuizen Roger E G Schutgens APACHE-AF Investigators Isabelle C van Gelder
rdfs:label
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial
skos:prefLabel
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial
schema:name
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial
p:P50
wds:Q36030528-7B405AE2-BE9E-4303-B60E-92B9577C5B25 wds:Q36030528-99555C49-1C5B-4FAF-B754-4333BF1C6D9D wds:Q36030528-1C2FB46A-2443-4B21-923E-94643B39B9C0 wds:Q36030528-D5122EE3-EC36-4514-B67C-6DCDEE229308 wds:Q36030528-8243ADFE-106F-4B5C-A81D-30343946BF7E
wdt:P50
wd:Q59244945 wd:Q57303440 wd:Q114291735 wd:Q85898396 wd:Q58370115
p:P1476
wds:Q36030528-15B97B14-2B7E-4E8F-98A2-B6A5AFB2F029
wdt:P1476
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial
p:P304
wds:Q36030528-0792268A-6AB1-457B-A68B-3EFF3C319926
wdt:P304
393
p:P31
wds:Q36030528-352540B7-BDA6-460C-BA44-D02A8CFDE0D8
wdt:P31
wd:Q13442814
p:P921
wds:Q36030528-88A403D9-F2EE-4458-8174-0CAB1BDF4312 wds:Q36030528-A0CD643C-9310-4F0C-B3D3-5B934A2C5207 wds:Q36030528-A9E347E7-D546-4E75-9DEA-C3A031863ABB wds:Q36030528-353B55F5-D142-4522-BAA3-803668686BFA
wdt:P921
wd:Q111908491 wd:Q414462 wd:Q63279445 wd:Q815819
p:P698
wds:Q36030528-ADA91EC5-498C-4A8D-A290-091FA27250AD
wdtn:P698
n13:26340977
wdt:P698
26340977
p:P1433
wds:Q36030528-26B268F6-ADD0-41A4-AC38-DBE58C2F0CC3
wdt:P1433
wd:Q7840023
p:P478
wds:Q36030528-50D9E8B6-F163-47C8-A4C3-3AFD0E40C863
wdt:P478
16
p:P356
wds:Q36030528-6FB06751-D302-4A8A-9D8D-6F4C53E06C52
wdtn:P356
n12:S13063-015-0898-4
wdt:P356
10.1186/S13063-015-0898-4
p:P5875
wds:Q36030528-FA44F21A-57DA-46D7-A4F2-09A05C0F30A6
wdt:P5875
281496537
p:P6179
wds:Q36030528-DEA2EBD8-DAC6-4820-BDDB-FC638702C059
wdt:P6179
1002048192
p:P932
wds:Q36030528-431C5F37-ECD5-4DC1-BC91-E484E7BDEF00
wdt:P932
4560912